Matritech (NASDAQ - NMPS) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Matritech (NASDAQ - NMPS)

An SI Board Since April 1996

Posts	SubjectMarks	Bans	Symbol
849	17	0	NMPS

Emcee: angra manyu	Type: Unmoderated

Introduction Market Data Compact

This company, selling around $11, was mentioned by Individual Investor as a good buy. What do you think. I found the company info in one of the Web sites.

Matritech, Inc., based in Cambridge, MA, is using its proprietary NUCLEAR MATRIX PROTEIN (NMP) technology, discovered at the Massachusetts Institute of Technology (MIT) and Johns Hopkins University School of Medicine and licensed exclusively to Matritech, to develop and commercialize innovative serum-, cell-, and urine-based NMP diagnostics that enable physicians to reliably detect and monitor the presence of bladder, breast, colorectal, cervical and prostate cancers. The company recently received notification from the FDA that its NMP22 Test Kit for bladder cancer is approvable.

Kris

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
849	MZT/JAMA article out and Forbes Article forbes.com Forbes article New Test Spot	Savant	-	1/17/2006
848	do not live long and do not prosper	Ben Wa	-	12/17/2005
847	MZT on a two week long strong move. CC Nov 1, 8:30 AM. Tomorrow will tell the ta	Savant	-	10/31/2005
846	MATRITECH REPORTS NOTIFICATION OF MARKETING APPROVAL IN JAPAN FOR ITS NMP22(R) B	Savant	-	7/14/2005
845	OT-speaking of urine tests... One day, in line at the company cafeteria, Joe say	Savant	-	7/11/2005
844	You may want to monitor the Yahoo Board. Think NMPS is ready to move quickly a	darbyred	-	11/5/2003
843	Where is everyone. Holding this baby and it is running like mad.	ErnestPoe	-	11/4/2003
842	This may explain partly the sudden interest in micro cap biotech stocks. biz.yah	Bob Swift	-	6/3/2003
841	Could it be short covering ? The stock refused to go down in the past weeks and	Bob Swift	-	5/30/2003
840	What lit the fire under NMPS today... Up almost 10% and not a word from the com	The Vet	-	5/30/2003
839	Yahoo NMPS board = fantasy land.	Bob Swift	-	5/15/2003
838	I have been in for 3+ years too. My concerns is the inability of the management	Bob Swift	-	4/24/2003
837	Agree. I have been in it for over three years. My only concern is the Cytogen(C	darbyred	-	4/23/2003
836	Concur. S.	Savant	-	4/23/2003
835	Take advantage of the recent decline and call me from your yacht in about 5 year	GemSeeker	-	4/23/2003
834	Any intelligent life out there? The Yahoo board sucks.	Bob Swift	-	4/23/2003
833	Should they achieve the approval for non-diagnosed testing, the future should be	Savant	-	8/9/2002
832	It is probably time to sit and wait until next quarter's numbers are in. How	darbyred	-	8/9/2002
831	Seems they had 6 months worth a/o the report, we'll have to wait and see. Gu	Savant	-	8/8/2002
830	Do you think NMPS has enough cash to survive until it becomes profitable? The n	darbyred	-	8/8/2002
829	FDA Clears Matritech's NMP22-R- BladderChek-TM- To Test Patients for Bladder	Savant	-	8/1/2002
828	Matritech Reports Second Quarter Financial Results; Revenue Up 48 Percent for t	Savant	-	7/31/2002
827	Undestand that insiders started buying the stock shortly after the news on the b	darbyred	-	12/17/2001
826	And I'm ALL for reducing needless biopsies.. New Data Report Matritech's	Savant	-	12/10/2001
825	NMPS has improved specificity in their prostate cancer test/per company news. Be	Savant	-	12/10/2001

Go to reply# or date (mm/dd/yy):